DA 6886
Alternative Names: 5-HT4 agonist - Dong-A; DA-6886Latest Information Update: 28 Apr 2018
Price :
$50 *
At a glance
- Originator Dong-A Pharmaceutical
- Developer Dong-A ST
- Class Irritable bowel syndrome therapies
- Mechanism of Action Serotonin 4 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Irritable bowel syndrome
Highest Development Phases
- No development reported Irritable bowel syndrome
Most Recent Events
- 28 Apr 2018 No recent reports of development identified for phase-I development in Irritable-bowel-syndrome(In volunteers) in South Korea (PO)
- 27 Apr 2016 Phase I development is ongoing in South Korea
- 31 Dec 2013 Dong-A ST completes a phase I trial in Healthy volunteers in South Korea (NCT01633723)